Fennec Pharmaceuticals (FENC) Earnings Analysis

Fennec Pharmaceuticals (FENC) next reports earnings on 2026-08-13, consensus EPS 0.01 USD. Last quarter (2026-05-14) it beat with EPS 0.01 USD vs -0.02 USD est (+150%). It has beaten estimates in 2/6 recent quarters (33%). Trailing P/E -33.60.

Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades

When does FENC next report earnings?

Next earnings date2026-08-13
Consensus EPS estimate0.01 USD
Revenue estimate0.02B

FENC earnings history — beats and misses

Quarter (report date)EPS actualEPS est.SurpriseResult
2026-05-140.01 USD-0.02 USD+150%Beat
2026-03-24-0.11 USD0.03 USD-466.7%Miss
2025-11-13-0.02 USD-0.08 USD+75%Beat
2025-08-14-0.11 USD-0.06 USD-83.3%Miss
2025-03-10-0.06 USD0.56 USD-110.7%Miss
2024-11-07-0.21 USD-0.13 USD-61.5%Miss

Beat rate: 2/6 (33%) over reported quarters with consensus data.

FENC valuation and analyst view

Trailing P/E-33.60
Trailing EPS-0.24394 USD
Price / book9.41
Dividend yield0.00%
Market cap0.29B
Analyst consensusBuy (7 buy / 0 hold / 0 sell)
Avg price target16 USD

Related research pages

Frequently asked questions

When is Fennec Pharmaceuticals (FENC)'s next earnings date?

Fennec Pharmaceuticals is next scheduled to report on 2026-08-13, with a consensus EPS estimate of 0.01 USD and revenue estimate of 0.02B.

Did FENC beat earnings last quarter?

In its 2026-05-14 report, FENC posted EPS of 0.01 USD versus a -0.02 USD estimate — a beat of 150%.

What is FENC's earnings track record?

Over the last 6 reported quarters with consensus data, FENC beat estimates 2 times (33%).

What is FENC's current P/E ratio and EPS?

FENC trades at a trailing P/E of -33.60 on trailing EPS of -0.24394221808014913 USD.

What do analysts rate FENC?

Analyst consensus is "Buy" across 7 ratings (0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell). Average 12-month price target: 16 USD.